I understand that that trial used high dose clofarabine whilst Sheba 2.0 used a lower dose. Still believe there is some merit in your view just like Mason’s find on the Ara-C combo. P1 should should remove any doubt that the market has.
Cardioprotection thread, page-439
-
- There are more pages in this discussion • 170 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.81 |
Change
-0.010(0.55%) |
Mkt cap ! $304.8M | |||
| Open | High | Low | Value | Volume |
| $1.83 | $1.84 | $1.78 | $249.6K | 138.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 390 | $1.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.81 | 4450 | 2 |
View Market Depth
| Last trade - 15.22pm 27/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |